The Alterations of Serum IgG Fucosylation as a Potential Additional New Diagnostic Marker in Advanced Endometriosis

References

• Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354. doi:10.1016/j.ajog.2018.12.039
   Web of Science ®Google Scholar
• Johnson NP, Hummelsho L. Consensus on current management of endometriosis. Hum Reprod. 2013;28:1552–1568. doi:10.1093/humrep/det050
   PubMed Web of Science ®Google Scholar
• Dunselman G, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400–412. doi:10.1093/humrep/det457
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101(4):927–935. doi:10.1016/j.fertnstert.2014.02.012
   PubMed Web of Science ®Google Scholar
• Andrews WC, Buttram VC, Behrman SJ. Revised American fertility society classification of endometriosis: 1985. Fertil Steril. 1985;44:7–8.
   Web of Science ®Google Scholar
• Canis M, Donnez JG, Guzick DS, et al. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67:817–821. doi:10.1016/S0015-0282(97)81391-X
   PubMed Web of Science ®Google Scholar
• Kyama CM, Debrock S, Mwenda JM, D’Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 2003;2(1):123. doi:10.1186/1477-7827-1-123
   Google Scholar
• Hyun Ahn S, Monsanto SP, Miller C, Singh SS, Thomas R, Tayade C. Pathophysiology and immune dysfunction in endometriosis. Biomed Res Int. 2015;2015:795976. doi:10.1155/2015/795976
   PubMed Web of Science ®Google Scholar
• Vlahos NF, Kalampokas T, Fotiou S. Endometriosis and ovarian cancer: a review. Gynecol Endocrinol. 2010;26(3):213–219. doi:10.1080/09513590903184050
   PubMed Web of Science ®Google Scholar
• Czyzyk A, Podfigurna A, Szeliga A, Meczekalski B. Update on endometriosis pathogenesis. Minerva Ginecol. 2017;69(5):447–464. doi:10.23736/S0026-4784.17.04048-5
   PubMed Web of Science ®Google Scholar
• Ruderman R, Pavone ME. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects. Minerva Ginecol. 2017;69(3):286–294. doi:10.23736/S0026-4784.17.04042-4
   PubMed Web of Science ®Google Scholar
• Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril. 1992;58(2):290–295. doi:10.1016/s0015-0282(16)55224-8
   PubMed Web of Science ®Google Scholar
• Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril. 2001;75(1):1–10. doi:10.1016/s0015-0282(00)01630-7
   PubMed Web of Science ®Google Scholar
• Patel BG, Lenk EE, Lebovic DI, Shu Y, Yu J, Taylor RN. Pathogenesis of endometriosis: interaction between endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol. 2018;50:50–60. doi:10.1016/j.bpobgyn.2018.01.006
   PubMed Web of Science ®Google Scholar
• Routier FH, Hounsell EF, Rudd PM, et al. Quantitation of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: a critical evaluation of different methods. J Immunol Methods. 1998;213:113–130. doi:10.1016/s0022-1759(98)00032-5
   PubMed Web of Science ®Google Scholar
• Borrok MJ, Jung ST, Kang TH, Monzingo AF, Georgiou G. Revisiting the role of glycosylation in the structure of human IgG Fc. ACS Chem Biol. 2012;7:1596–1602. doi:10.1021/cb300130k
   PubMed Web of Science ®Google Scholar
• Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol. 2003;325:979–989. doi:10.1016/s0022-2836(02)01250-0
   PubMed Web of Science ®Google Scholar
• Shields RL, Lai J, Keck R, et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem. 2002;277:26733–26740. doi:10.1074/jbc.M202069200
   PubMed Web of Science ®Google Scholar
• Sondermann P, Huber R, Oosthuizen V, Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature. 2000;406(6793):267–273. doi:10.1038/35018508
   PubMed Web of Science ®Google Scholar
• Ferrara C, Grau S, Jager C, et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci U S A. 2011;108:12669–12674. doi:10.1073/pnas.1108455108
   PubMed Web of Science ®Google Scholar
• Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985;316:52–457. doi:10.1038/316452a0
   Web of Science ®Google Scholar
• Ramakrishna C, Newo AN, Shen YW, Cantin E. Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis. PLoS Pathog. 2011;7:e1002071. doi:10.1371/journal.ppat.1002071
   PubMed Web of Science ®Google Scholar
• Mizuochi T, Taniguchi T, Shimizu A, Kobata A. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J Immunol. 1982;129:2016–2020.
   PubMed Web of Science ®Google Scholar
• Shibata-Koyama M, Iida S, Okazaki A, et al. The N-linked oligosaccharide at Fc gamma RIIIa Asn-45: an inhibitory element for high Fc gammaRIIIa binding affinity to IgG glycoforms lacking core fucosylation. Glycobiology. 2009;19:126–134. doi:10.1093/glycob/cwn110
   PubMed Web of Science ®Google Scholar
• Mizushima T, Yagi H, Takemoto E, et al. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells. 2011;16(11):1071–1080. doi:10.1111/j.1365-2443.2011.01552.x
   PubMed Web of Science ®Google Scholar
• Li J, Hsu HC, Mountz JD, Allen JG. Unmasking fucosylation: from cell adhesion to immune system regulation and diseases. Cell Chem Biol. 2018;25(5):499–512. doi:10.1016/j.chembiol.2018.02.005
   PubMed Web of Science ®Google Scholar
• Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem. 2008;143:725–729. doi:10.1093/jb/mvn011
   PubMed Web of Science ®Google Scholar
• Ma B, Simala-Grant JL, Taylor DE. Fucosylation in prokaryotes and eukaryotes. Glycobiology. 2006;16:158–184. doi:10.1093/glycob/cwl040
   PubMed Web of Science ®Google Scholar
• Brinkman-van der Linden EC, de Haan PF, Havenaar EC, van Dijk W. Inflammation-induced expression of sialyl LewisX is not restricted to alpha1-acid glycoprotein but also occurs to a lesser extent on alpha1-antichymotrypsin and haptoglobin. Glycoconjugate J. 1998;15:177–182. doi:10.1023/a:1006972307166
   PubMed Web of Science ®Google Scholar
• Goodarzi MT, Axford JS, Varanasi SS, et al. Sialyl Lewis(x) expression on IgG in rheumatoid arthritis and other arthritic conditions: a preliminary study. Glycoconj J. 1998;15:1149–1154. doi:10.1023/a:1006920007227
   PubMed Web of Science ®Google Scholar
• Li J, Hsu HC, Ding Y, et al. Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis. Arthritis Rheumatol. 2014;66:2368–2379. doi:10.1002/art.38711
   PubMed Web of Science ®Google Scholar
• Ryden I, Pahlsson P, Lundblad A, Skogh T. Fucosylation of α1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis. Clin Chim Acta. 2002;317:221–229. doi:10.1016/s0009-8981(01)00803-8
   PubMed Web of Science ®Google Scholar
• Thompson S, Kelly CA, Griffiths ID, Turner GA. Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease. Clin Chim Acta. 1989;184:251–258. doi:10.1016/0009-8981(89)90058-2
   PubMed Web of Science ®Google Scholar
• Sarrats A, Saldova R, Pla E, et al. Glycosylation of liver acute phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin Appl. 2010;4:432–448. doi:10.1002/prca.200900150
   PubMed Web of Science ®Google Scholar
• Miyoshi J, Yajima T, Okamoto S, et al. Ectopic expression of blood type antigens in inflamed mucosa with higher incidence of FUT2 secretor status in colonic Crohn’s disease. J Gastroenterol. 2011;46:1056–1063. doi:10.1007/s00535-011-0425-7
   PubMed Web of Science ®Google Scholar
• Maroni L, van de Graaf SFJ, Hohenester SD, et al. Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn’s disease–a comprehensive review. Clin Rev Allergy Immunol. 2015;48:182–191. doi:10.1007/s12016-014-8423-1
   PubMed Web of Science ®Google Scholar
• Kapur R, Kustiawan I, Vestrheim A, et al. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood. 2014;123:471–480. doi:10.1182/blood-2013-09-527978
   PubMed Web of Science ®Google Scholar
• Yamashita K, Kochibe N, Ohkura T, Ueda I, Kobata A. Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem. 1985;260:4688–4693. doi:10.1016/S0021-9258(18)89125-6
   PubMed Web of Science ®Google Scholar
• Yan L, Wilkins PP, Alvarez-Manilla G, Do SI, Smith DF, Cummings RD. Immobilized Lotus tetragonolobus agglutinin binds oligosaccharides containing the Le(x) determinant. Glycoconj J. 1997;14:45–55. doi:10.1023/a:1018508914551
   PubMed Web of Science ®Google Scholar
• Loris R, De Greve H, Dao-Thi MH, Messens J, Imberty A, Wyns L. Structural basis of carbohydrate recognition by lectin II from Ulex europaeus, a protein with a promiscuous carbohydrate binding site. J Mol Biol. 2000;301:987–1002. doi:10.1006/jmbi.2000.4016
   PubMed Web of Science ®Google Scholar
• Sołkiewicz K, Krotkiewski H, Jędryka M, Kratz EM. Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis. Sci Rep. 2021;11:5586. doi:10.1038/s41598-021-85200-x
   PubMed Web of Science ®Google Scholar
• Kokot I, Piwowar A, Jędryka M, Sołkiewicz K, Kratz EM. Diagnostic significance of selected serum inflammatory markers in women with advanced. Int J Mol Sci. 2021;22(5):2295. doi:10.3390/ijms22052295
   PubMed Web of Science ®Google Scholar
• Ey PL, Prowse SJ, Jenkin CR. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978;15:429–436. doi:10.1016/0161-5890(78)90070-6
   PubMedGoogle Scholar
• Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev. 2009;8:543–548. doi:10.1016/j.autrev.2009.01.013
   PubMed Web of Science ®Google Scholar
• Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis? Autoimmun Rev. 2012;11:806–814. doi:10.1016/j.autrev.2012.01.005
   PubMed Web of Science ®Google Scholar
• Berkes E, Muzinic A, Rigo J, Tinneberg HR, Oehmke F. The analysis of the human plasma N-glycome in endometriosis patients. Eur J Obstet Gynecol Reprod Biol. 2013;171:107–115. doi:10.1016/j.ejogrb.2013.08.008
   PubMed Web of Science ®Google Scholar
• Corzo C, Barrientos Santillan N, Westin SN, Ramirez PT. Updates on Conservative Management of Endometrial Cancer. J Minim Invasive Gynecol. 2018;25(2):308–313. doi:10.1016/j.jmig.2017.07.022
   PubMed Web of Science ®Google Scholar
• Heong V, Ngoi N, Tan DS. Update on immune checkpoint inhibitors in gynecological cancers. J GynecolOncol. 2017;28(2):e20. doi:10.3802/jgo.2017.28.e20
   PubMed Web of Science ®Google Scholar
• Menderes G, Hicks C, Black JD, Schwab CL, Santin AD. Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers. Expert Opin Biol Ther. 2016;16(8):989–1004. doi:10.1080/14712598.2016.1177018
   PubMed Web of Science ®Google Scholar
• Saldova R, Royle L, Radcliffe CM, et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 2007;17:1344–1356. doi:10.1093/glycob/cwm100
   PubMed Web of Science ®Google Scholar
• Ohmi Y, Ise W, Harazono A, et al. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun. 2016;7:11205. doi:10.1038/ncomms11205
   PubMed Web of Science ®Google Scholar
• Komaromy A, Reider B, Jarvas G, Guttman A. Glycoprotein biomarkers and analysis in chronic obstructive pulmonary disease and lung cancer with special focus on serum immunoglobulin G. Clin Chim Acta. 2020;506:204–213. doi:10.1016/j.cca.2020.03.041
   PubMed Web of Science ®Google Scholar
• Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol. 1987;156:783189. doi:10.1016/0002-9378(87)90333-4
   Web of Science ®Google Scholar
• Khan KN, Masuzaki H, Fujishita A, Kitajima M, Sekine I, Ishimaru T. Differential macrophage infiltration in early and advanced endometriosis and adjacent peritoneum. Fertil Steril. 2004;81:652–661. doi:10.1016/j.fertnstert.2003.07.037
   PubMed Web of Science ®Google Scholar
• Khan KN, Masuzaki H, Fujishita A, et al. Regulation of hepatocyte growth factor by basal and stimulated macrophages in women with endometriosis. Hum Reprod. 2005;20:49–60. doi:10.1093/humrep/deh525
   PubMed Web of Science ®Google Scholar
• Khan KN, Kitajima M, Hiraki H, et al. Immunopathogenesis of pelvic endometriosis: role of hepatocyte growth factor, macrophages and ovarian steroids. Am J Reprod Immunol. 2008;60:383–404. doi:10.1111/j.1600-0897.2008.00643.x
   PubMed Web of Science ®Google Scholar
• Okazaki A, Shoji-Hosaka E, Nakamura K, et al. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. J Mol Biol. 2004;336:1239–1249. doi:10.1016/j.jmb.2004.01.007
   PubMed Web of Science ®Google Scholar
• Ferrara C, Stuart F, Sondermann P, Brünker P, Umaña P. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J Biol Chem. 2006;281:5032. doi:10.1074/jbc.M510171200
   PubMed Web of Science ®Google Scholar
• Shibata-Koyama M, Iida S, Misaka H, et al. Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils. Exp Hematol. 2009;37(3):309–321. doi:10.1016/j.exphem.2008.11.006
   PubMed Web of Science ®Google Scholar
• Becker DJ, Lowe JB. Fucose: biosynthesis and biological function in mammals. Glycobiology. 2003;13:41–53. doi:10.1093/glycob/cwg054
   PubMed Web of Science ®Google Scholar
• Chen HL. Lewis glyco-epitopes: structure, biosynthesis, and functions. In: Wu AM, editor. The Molecular Immunology of Complex Carbohydrates-3. New York, Dordrecht, Heidelberg, London: Springer; 2011:53–80.
   Google Scholar
• Castilho A, Gruber C, Thader A, et al. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation. MAbs. 2015;7:863–870. doi:10.1080/19420862.2015.1053683
   PubMed Web of Science ®Google Scholar
• Kratz EM, Borysewicz K, Katnik-Prastowska I. Terminal monosaccharide screening of synovial immunoglobulins G and A for the early detection of rheumatoid arthritis. Rheumatol Int. 2010;30(10):1285–1292. doi:10.1007/s00296-009-1139-5
   PubMed Web of Science ®Google Scholar
• Kratz EM, Ferens-Sieczkowska M, Faundez R, Kątnik-Prastowska I. Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients. Glycoconj J. 2014;31(1):51–60. doi:10.1007/s10719-013-9501-y
   PubMed Web of Science ®Google Scholar
• Flögel M, Lauc G, Gornik I, Macek B. Fucosylation and galactosylation of IgG heavy chains differ between acute and remission phases of juvenile chronic arthritis. Clin Chem Lab Med. 1998;36(2):99–102. doi:10.1515/CCLM.1998.018
   PubMed Web of Science ®Google Scholar
• Gornik I, Maravić G, Dumić J, Flögel M, Lauc G. Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin Biochem. 1999;32(8):605–608. doi:10.1016/s0009-9120(99)00060-0
   PubMed Web of Science ®Google Scholar
• Zauner G, Selman MH, Bondt A, et al. Glycoproteomic analysis of antibodies. Mol Cell Proteomics. 2013;12:856–865. doi:10.1074/mcp.R112.026005
   PubMed Web of Science ®Google Scholar
• Niwa R, Shoji-Hosaka E, Sakurada M, et al. Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Res. 2004;64(6):2127–2133. doi:10.1158/0008-5472.can-03-2068
   PubMed Web of Science ®Google Scholar
• Niwa R, Natsume A, Uehara A, et al. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J Immunol Methods. 2005;306(1–2):151–160. doi:10.1016/j.jim.2005.08.009
   PubMed Web of Science ®Google Scholar
• Masuda K, Kubota T, Kaneko E, et al. Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Mol Immunol. 2007;44(12):3122–3131. doi:10.1016/j.molimm.2007.02.005
   PubMed Web of Science ®Google Scholar
• Peipp M, Lammerts van Bueren JJ, Schneider-Merck T, et al. Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells. Blood. 2008;112(6):2390–2399. doi:10.1182/blood-2008-03-144600
   PubMed Web of Science ®Google Scholar
• Van de Bovenkamp FS, Hafkenscheid L, Rispens T, Rombouts Y. The emerging importance of IgG Fab glycosylation in immunity. J Immunol. 2016;196:1435–1441. doi:10.4049/jimmunol.1502136
   PubMed Web of Science ®Google Scholar
• Van Damme EJM. Lectins as tools to select for glycosylated proteins. In: Gevaert K, Vandekerckhove J, editors. Gel-Free Proteomics. Springer Protocols; 2011:289–297.
   Google Scholar